Vertex Pharmaceuticals Inc (VRTX)
404.59
+4.73
(+1.18%)
USD |
NASDAQ |
Apr 23, 16:00
404.59
0.00 (0.00%)
After-Hours: 18:44
Vertex Pharmaceuticals Price: 404.59 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2024 | 397.30 | 406.34 | 396.00 | 399.86 | 1.132M |
| Apr 19, 2024 | 394.72 | 396.98 | 391.25 | 394.28 | 1.342M |
| Apr 18, 2024 | 394.19 | 396.14 | 391.01 | 393.48 | 949091.0 |
| Apr 17, 2024 | 394.94 | 398.11 | 392.03 | 393.10 | 881020.0 |
| Apr 16, 2024 | 396.88 | 398.49 | 392.81 | 394.17 | 695469.0 |
| Apr 15, 2024 | 400.00 | 402.49 | 396.69 | 397.36 | 1.374M |
| Apr 12, 2024 | 396.57 | 400.14 | 393.76 | 396.55 | 1.200M |
| Apr 11, 2024 | 404.30 | 404.69 | 398.85 | 400.23 | 1.060M |
| Apr 10, 2024 | 399.89 | 401.00 | 394.81 | 397.58 | 1.027M |
| Apr 09, 2024 | 406.00 | 406.45 | 399.30 | 404.48 | 727107.0 |
| Apr 08, 2024 | 403.45 | 404.60 | 399.00 | 404.22 | 751935.0 |
| Apr 05, 2024 | 404.29 | 409.93 | 400.83 | 406.67 | 695728.0 |
| Apr 04, 2024 | 412.64 | 412.64 | 403.15 | 404.01 | 957469.0 |
| Apr 03, 2024 | 409.45 | 414.96 | 408.25 | 408.81 | 728985.0 |
| Apr 02, 2024 | 419.00 | 420.87 | 406.73 | 409.42 | 974829.0 |
| Apr 01, 2024 | 420.43 | 421.45 | 414.74 | 420.48 | 767752.0 |
| Mar 28, 2024 | 419.48 | 420.67 | 415.06 | 418.01 | 1.092M |
| Mar 27, 2024 | 420.30 | 420.42 | 412.65 | 417.32 | 905446.0 |
| Mar 26, 2024 | 417.38 | 419.55 | 414.86 | 418.46 | 952561.0 |
| Mar 25, 2024 | 415.66 | 418.28 | 414.97 | 416.03 | 732827.0 |
| Mar 22, 2024 | 417.75 | 417.75 | 412.19 | 415.66 | 821734.0 |
| Mar 21, 2024 | 415.61 | 419.26 | 414.00 | 415.71 | 895298.0 |
| Mar 20, 2024 | 414.33 | 414.51 | 409.02 | 412.11 | 796425.0 |
| Mar 19, 2024 | 412.51 | 415.70 | 411.10 | 415.20 | 859933.0 |
| Mar 18, 2024 | 410.49 | 415.50 | 409.24 | 411.38 | 926467.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
164.61
Minimum
May 13 2019
446.08
Maximum
Jan 30 2024
265.12
Average
256.12
Median
Price Benchmarks
| Amgen Inc | 273.60 |
| Eli Lilly and Co | 745.13 |
| Regeneron Pharmaceuticals Inc | 907.34 |
| Alpine Immune Sciences Inc | 64.51 |
| Moderna Inc | 107.80 |
Price Related Metrics
| PE Ratio | 29.13 |
| PS Ratio | 10.68 |
| PEG Ratio | 3.526 |
| Price to Book Value | 5.945 |
| Price to Free Cash Flow | 32.15 |
| Earnings Yield | 3.43% |
| Market Cap | 104.51B |
| PEGY Ratio | 3.526 |
| Operating PE Ratio | 24.47 |
| Normalized PE Ratio | 26.38 |